{"DataElement":{"publicId":"7533518","version":"1","preferredName":"Disease or Disorder Primary Immunodeficiency Syndrome Or Primary Immune Regulatory Disorder Description Name","preferredDefinition":"Text term to describe the primary immunodeficiency syndrome or primary immune regulatory disorder.","longName":"PID_PIRD_DIS_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"7533517","version":"1","preferredName":"Disease or Disorder Primary Immunodeficiency Syndrome Or Primary Immune Regulatory Disorder Description","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Immunodeficiency disease that arises independent of another pathologic process, disease, or injury._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A group of immune diseases characterized predominantly by immune dysregulation leading to organ-specific autoimmunity, excessive inflammation, and non-malignant lymphoproliferation. Unlike classical primary immunodeficiencies, susceptibility to infections is typically less prominent in these disorders._A written or verbal account, representation, statement, or explanation of something.","longName":"2404658v1.0:7533515v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7533515","version":"1","preferredName":"Primary Immunodeficiency Syndrome Or Primary Immune Regulatory Disorder Description","preferredDefinition":"Immunodeficiency disease that arises independent of another pathologic process, disease, or injury.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:A group of immune diseases characterized predominantly by immune dysregulation leading to organ-specific autoimmunity, excessive inflammation, and non-malignant lymphoproliferation. Unlike classical primary immunodeficiencies, susceptibility to infections is typically less prominent in these disorders.:A written or verbal account, representation, statement, or explanation of something.","longName":"C152105:C37998:C176600:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Immunodeficiency Syndrome","conceptCode":"C152105","definition":"Immunodeficiency disease that arises independent of another pathologic process, disease, or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary Immune Regulatory Disorder","conceptCode":"C176600","definition":"A group of immune diseases characterized predominantly by immune dysregulation leading to organ-specific autoimmunity, excessive inflammation, and non-malignant lymphoproliferation. Unlike classical primary immunodeficiencies, susceptibility to infections is typically less prominent in these disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6853381-5D74-06D5-E053-4EBD850A0E44","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6853381-5D85-06D5-E053-4EBD850A0E44","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeDescription":"2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7515390","version":"1","preferredName":"Immunodeficiency Syndrome Name","preferredDefinition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral._The words or language units by which a thing is known.","longName":"IMMUNODEF_SYND_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"70","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"CD3ζ","valueDescription":"T-Cell Surface Glycoprotein CD3 Zeta Chain Immunodeficiency Syndrome","ValueMeaning":{"publicId":"5156210","version":"1","preferredName":"T-Cell Surface Glycoprotein CD3 Zeta Chain Immunodeficiency Syndrome","longName":"5156210","preferredDefinition":"T-cell surface glycoprotein CD3 zeta chain (164 aa, ~18 kDa) is encoded by the human CD247 gene. This protein is involved in T-cell intracellular signaling.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD3 Zeta Chain","conceptCode":"C38903","definition":"T-cell surface glycoprotein CD3 zeta chain (164 aa, ~18 kDa) is encoded by the human CD247 gene. This protein is involved in T-cell intracellular signaling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19987B-4254-0FE9-E050-BB89AD435F86","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C88749-40E1-7951-E053-4EBD850AFCD7","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CD3ε","valueDescription":"T-Cell Surface Glycoprotein CD3 Epsilon Chain Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7515396","version":"1","preferredName":"T-Cell Surface Glycoprotein CD3 Epsilon Chain Immunodeficiency Syndrome","longName":"7515396","preferredDefinition":"T-cell surface glycoprotein CD3 epsilon chain (207 aa, ~23 kDa) is encoded by the human CD3E gene. This protein plays a role in immune receptor signaling.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD3 Epsilon Chain","conceptCode":"C25792","definition":"T-cell surface glycoprotein CD3 epsilon chain (207 aa, ~23 kDa) is encoded by the human CD3E gene. This protein plays a role in immune receptor signaling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C88749-40EE-7951-E053-4EBD850AFCD7","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C88749-4107-7951-E053-4EBD850AFCD7","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CD3δ","valueDescription":"T-Cell Surface Glycoprotein CD3 Delta Chain Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7515397","version":"1","preferredName":"T-Cell Surface Glycoprotein CD3 Delta Chain Immunodeficiency Syndrome","longName":"7515397","preferredDefinition":"T-cell surface glycoprotein CD3 delta chain (171 aa, ~19 kDa) is encoded by the human CD3D gene. This protein is involved in T-cell-mediated immunity.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD3 Delta Chain","conceptCode":"C38899","definition":"T-cell surface glycoprotein CD3 delta chain (171 aa, ~19 kDa) is encoded by the human CD3D gene. This protein is involved in T-cell-mediated immunity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C88749-4113-7951-E053-4EBD850AFCD7","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C88749-412C-7951-E053-4EBD850AFCD7","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CD3 γ Deficiency","valueDescription":"T-Cell Surface Glycoprotein CD3 Gamma Chain Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7515398","version":"1","preferredName":"T-Cell Surface Glycoprotein CD3 Gamma Chain Immunodeficiency Syndrome","longName":"7515398","preferredDefinition":"T-cell surface glycoprotein CD3 gamma chain (182 aa, ~20 kDa) is encoded by the human CD3G gene. This protein plays a role in T-cell receptor-mediated signaling.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD3 Gamma Chain","conceptCode":"C38901","definition":"T-cell surface glycoprotein CD3 gamma chain (182 aa, ~20 kDa) is encoded by the human CD3G gene. This protein plays a role in T-cell receptor-mediated signaling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C88749-4138-7951-E053-4EBD850AFCD7","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C88749-4151-7951-E053-4EBD850AFCD7","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Cartilage Hair Hypoplasia","valueDescription":"Cartilage Hair Hypoplasia","ValueMeaning":{"publicId":"3322411","version":"1","preferredName":"Cartilage Hair Hypoplasia","longName":"3322411","preferredDefinition":"A rare autosomal recessive inherited disorder caused by mutation in the gene for RNAase RMRP. It is characterized by short-limb dwarfism, presence of fine sparse hair, and T-and B-cell immunodeficiency.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cartilage Hair Hypoplasia","conceptCode":"C61245","definition":"A rare autosomal recessive inherited disorder caused by mutation in the gene for RNAase RMRP. It is characterized by short-limb dwarfism, presence of fine sparse hair, and T-and B-cell immunodeficiency.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BDAA-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C88749-415B-7951-E053-4EBD850AFCD7","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CARD 11/CIS or SCID w high IgE","valueDescription":"Immunodeficiency 11B with Atopic Dermatitis","ValueMeaning":{"publicId":"7515399","version":"1","preferredName":"Immunodeficiency 11B with Atopic Dermatitis","longName":"7515399","preferredDefinition":"An autosomal dominant condition caused by mutation(s) in the CARD11 gene, encoding caspase recruitment domain-containing protein 11. It is characterized by the onset of moderate to severe atopic dermatitis in early childhood, defects in T-cell activation, increased IgE, and eosinophilia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency 11B with Atopic Dermatitis","conceptCode":"C176630","definition":"An autosomal dominant condition caused by mutation(s) in the CARD11 gene, encoding caspase recruitment domain-containing protein 11. It is characterized by the onset of moderate to severe atopic dermatitis in early childhood, defects in T-cell activation, increased IgE, and eosinophilia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C88749-4166-7951-E053-4EBD850AFCD7","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C88749-417F-7951-E053-4EBD850AFCD7","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CARD 11/BENTA","valueDescription":"B-Cell Expansion with NFKB and T-Cell Anergy","ValueMeaning":{"publicId":"7515400","version":"1","preferredName":"B-Cell Expansion with NFKB and T-Cell Anergy","longName":"7515400","preferredDefinition":"An autosomal dominant condition caused by heterozygous germline gain-of-function mutation(s) in the CARD11 gene, encoding caspase recruitment domain-containing protein 11. It is characterized by splenomegaly and lymphocytosis resulting from polyclonal expansion of B-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Cell Expansion with NFKB and T-Cell Anergy","conceptCode":"C176791","definition":"An autosomal dominant condition caused by heterozygous germline gain-of-function mutation(s) in the CARD11 gene, encoding caspase recruitment domain-containing protein 11. It is characterized by splenomegaly and lymphocytosis resulting from polyclonal expansion of B-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C88749-4189-7951-E053-4EBD850AFCD7","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C88749-41A2-7951-E053-4EBD850AFCD7","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"MVK","valueDescription":"Mevalonate Kinase Deficiency","ValueMeaning":{"publicId":"7515001","version":"1","preferredName":"Mevalonate Kinase Deficiency","longName":"7515001","preferredDefinition":"A very rare autosomal recessive disorder of cholesterol biosynthesis. It is caused by a deficiency of the enzyme mevalonate kinase, resulting in the accumulation of mevalonic acid in the urine. Signs and symptoms include psychomotor retardation, ataxia, recurrent fevers, skin rash, hepatosplenomegaly, and lymphadenopathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mevalonate Kinase Deficiency","conceptCode":"C84890","definition":"A very rare autosomal recessive disorder of cholesterol biosynthesis. It is caused by a deficiency of the enzyme mevalonate kinase, resulting in the accumulation of mevalonic acid in the urine. Signs and symptoms include psychomotor retardation, ataxia, recurrent fevers, skin rash, hepatosplenomegaly, and lymphadenopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C86B77-E354-619D-E053-4EBD850A30E4","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E823-619D-E053-4EBD850A30E4","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"NFAT5","valueDescription":"NFAT5 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7513093","version":"1","preferredName":"NFAT5 Gene Immunodeficiency Syndrome","longName":"7513093","preferredDefinition":"This gene is involved in gene transcription and cellular stress responses.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NFAT5 Gene","conceptCode":"C93131","definition":"This gene is involved in gene transcription and cellular stress responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47CEEE2-14C8-59E3-E053-4EBD850A13A3","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E839-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"NFKB1","valueDescription":"NFKB1 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3265639","version":"1","preferredName":"NFKB1 Gene Immunodeficiency Syndrome","longName":"3265639","preferredDefinition":"This gene is involved in the regulation of apoptosis, signal transduction and gene transcription.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NFKB1 Gene","conceptCode":"C94295","definition":"This gene is involved in the regulation of apoptosis, signal transduction and gene transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABE36AD2-3AE9-4D30-E040-BB89AD433C58","latestVersionIndicator":"Yes","beginDate":"2011-09-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-01","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E844-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"NFKB2","valueDescription":"NFKB2 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"6142141","version":"1","preferredName":"NFKB2 Gene Immunodeficiency Syndrome","longName":"6142141","preferredDefinition":"This gene plays a role in transcriptional regulation, signal transduction and inflammatory responses.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NFKB2 Gene","conceptCode":"C18404","definition":"This gene plays a role in transcriptional regulation, signal transduction and inflammatory responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67CCB734-EE28-4B40-E053-F662850A71CC","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E84F-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"NFKBIA","valueDescription":"NFKBIA Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3781717","version":"1","preferredName":"NFKBIA Gene Immunodeficiency Syndrome","longName":"3781717","preferredDefinition":"This gene plays a role in signal transduction and transcriptional activation of target genes. It is also involved in the inhibition of apoptosis.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NFKBIA Gene","conceptCode":"C26430","definition":"This gene plays a role in signal transduction and transcriptional activation of target genes. It is also involved in the inhibition of apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DEF60B15-64FA-62EE-E040-BB89AD431C60","latestVersionIndicator":"Yes","beginDate":"2013-06-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-06-12","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E85A-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"NIK","valueDescription":"NRK Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7513091","version":"1","preferredName":"NRK Gene Immunodeficiency Syndrome","longName":"7513091","preferredDefinition":"This gene is involved in intracellular signaling.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NRK Gene","conceptCode":"C88934","definition":"This gene is involved in intracellular signaling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47CEEE2-1479-59E3-E053-4EBD850A13A3","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E870-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"OTULIN","valueDescription":"OTULIN Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7515000","version":"1","preferredName":"OTULIN Gene Immunodeficiency Syndrome","longName":"7515000","preferredDefinition":"This gene plays a role in the removal of linear polyubiquitin chains from protein substrates.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"OTULIN Gene","conceptCode":"C176454","definition":"This gene plays a role in the removal of linear polyubiquitin chains from protein substrates.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C86B77-E331-619D-E053-4EBD850A30E4","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E87B-619D-E053-4EBD850A30E4","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"PRKCD","valueDescription":"PRKCD Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7513087","version":"1","preferredName":"PRKCD Gene Immunodeficiency Syndrome","longName":"7513087","preferredDefinition":"This gene plays a role in the regulation of both cell death and cell survival.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PRKCD Gene","conceptCode":"C150118","definition":"This gene plays a role in the regulation of both cell death and cell survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47CEEE2-13F0-59E3-E053-4EBD850A13A3","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E8BD-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"PSTPIP1","valueDescription":"PSTPIP1 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7514998","version":"1","preferredName":"PSTPIP1 Gene Immunodeficiency Syndrome","longName":"7514998","preferredDefinition":"This gene is involved in cytoskeletal modeling and immunoregulation.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PSTPIP1 Gene","conceptCode":"C176458","definition":"This gene is involved in cytoskeletal modeling and immunoregulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C86B77-E2EB-619D-E053-4EBD850A30E4","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E8DE-619D-E053-4EBD850A30E4","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"RELA","valueDescription":"RELA Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"2901300","version":"1","preferredName":"RELA Gene Immunodeficiency Syndrome","longName":"2901300","preferredDefinition":"This gene plays a role in transcriptional regulation and NFKB signal transduction.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RELA Gene","conceptCode":"C28646","definition":"This gene plays a role in transcriptional regulation and NFKB signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C2853C6-1976-4A3D-E040-BB89AD436E61","latestVersionIndicator":"Yes","beginDate":"2009-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-12","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E920-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"RELB","valueDescription":"RELB Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3743379","version":"1","preferredName":"RELB Gene Immunodeficiency Syndrome","longName":"3743379","preferredDefinition":"This gene is involved in transcriptional regulation of immune processes.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RELB Gene","conceptCode":"C105997","definition":"This gene is involved in transcriptional regulation of immune processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBD303D2-5F21-63D2-E040-BB89AD4339BB","latestVersionIndicator":"Yes","beginDate":"2013-05-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-05-03","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E92B-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"STK4","valueDescription":"STK4 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7513123","version":"1","preferredName":"STK4 Gene Immunodeficiency Syndrome","longName":"7513123","preferredDefinition":"This gene is involved in both protein phosphorylation and the hippo signaling pathway.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"STK4 Gene","conceptCode":"C99480","definition":"This gene is involved in both protein phosphorylation and the hippo signaling pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47D1C77-B453-7AD2-E053-4EBD850A9E39","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E999-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"TNFAIP3","valueDescription":"TNFAIP3 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3288476","version":"1","preferredName":"TNFAIP3 Gene Immunodeficiency Syndrome","longName":"3288476","preferredDefinition":"This gene may play a role in the regulation of apoptosis.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TNFAIP3 Gene","conceptCode":"C84928","definition":"This gene may play a role in the regulation of apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE7F3065-B956-7A52-E040-BB89AD435AC4","latestVersionIndicator":"Yes","beginDate":"2011-10-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-04","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E9BA-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"ZAP 70 deficiency","valueDescription":"Immunodeficiency 48; Selective T-Cell Defect; STCD","ValueMeaning":{"publicId":"7515579","version":"1","preferredName":"Immunodeficiency 48; Selective T-Cell Defect; STCD","longName":"7515579","preferredDefinition":"An autosomal recessive immunodeficiency caused by mutation(s) in the ZAP70 gene, encoding tyrosine-protein kinase ZAP-70. It is characterized by absent CD8+ cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency 48","conceptCode":"C176821","definition":"An autosomal recessive immunodeficiency caused by mutation(s) in the ZAP70 gene, encoding tyrosine-protein kinase ZAP-70. It is characterized by absent CD8+ cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-37A2-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-37BB-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"XMEN","valueDescription":"MAGT1 Deficiency","ValueMeaning":{"publicId":"7515580","version":"1","preferredName":"MAGT1 Deficiency","longName":"7515580","preferredDefinition":"A condition of decreased or absent presence or activity of magnesium transporter 1 protein. Deficiency of this protein is associated with X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia (XMEN).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-Linked Immunodeficiency with Magnesium Defect, Epstein-Barr Virus Infection and Neoplasia","conceptCode":"C126336","definition":"An X-linked recessive condition caused by mutation(s) in the MAGT1 gene, encoding magnesium transporter protein 1. It is characterized by CD4 lymphopenia, defective T-cell activation and susceptibility to severe chronic viral infections, particularly Epstein-Barr virus (EBV), which may lead to the development of EBV-associated B-cell lymphoproliferative disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-37C5-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-37DE-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"XL-Thrombocytopenia (less severe)","valueDescription":"Thrombocytopenia 1","ValueMeaning":{"publicId":"7515581","version":"1","preferredName":"Thrombocytopenia 1","longName":"7515581","preferredDefinition":"An X-linked recessive bleeding disorder caused by mutation(s) in the WAS gene, encoding Wiskott-Aldrich syndrome protein, resulting in thrombocytopenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenia 1","conceptCode":"C176617","definition":"An X-linked recessive bleeding disorder caused by mutation(s) in the WAS gene, encoding Wiskott-Aldrich syndrome protein, resulting in thrombocytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-37E8-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3801-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"XLP2/XIAP","valueDescription":"XIAP Deficiency","ValueMeaning":{"publicId":"5189572","version":"1","preferredName":"XIAP Deficiency","longName":"5189572","preferredDefinition":"A condition of decreased or absent presence of baculoviral IAP repeat-containing protein 4. Deficiency of this protein is associated with X-linked lymphoproliferative syndrome 2.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-linked Lymphoproliferative Syndrome 2","conceptCode":"C126295","definition":"An X-linked lymphoproliferative disorder caused by mutations in the XIAP gene. Clinical manifestations include hemophagocytic lymphohistiocytosis (often associated with EBV), dysgammaglobulinemia, and inflammatory bowel disease. Patients are at an increased risk of developing lymphoma, typically B-cell non-Hodgkin lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA23415-22C1-8B50-E050-BB89AD4351B0","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3815-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"XLP1/SAP","valueDescription":"X-linked Lymphoproliferative Syndrome 1","ValueMeaning":{"publicId":"7515582","version":"1","preferredName":"X-linked Lymphoproliferative Syndrome 1","longName":"7515582","preferredDefinition":"An X-linked recessive condition caused by mutation(s) in the SH2D1A gene, encoding SH2 domain-containing protein 1A. It is characterized by a susceptibility to severe EBV infection, acquired hypogammaglobulinemia, hemophagocytic lymphohistiocytosis, and/or lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-linked Lymphoproliferative Syndrome 1","conceptCode":"C170434","definition":"An X-linked recessive condition caused by mutation(s) in the SH2D1A gene, encoding SH2 domain-containing protein 1A. It is characterized by a susceptibility to severe EBV infection, acquired hypogammaglobulinemia, hemophagocytic lymphohistiocytosis, and/or lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3820-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3839-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"XL IL2RG","valueDescription":"X-Linked Severe Combined Immunodeficiency","ValueMeaning":{"publicId":"7515583","version":"1","preferredName":"X-Linked Severe Combined Immunodeficiency","longName":"7515583","preferredDefinition":"Rare congenital disorder inherited as an X-linked defect characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-Linked Severe Combined Immunodeficiency","conceptCode":"C4682","definition":"Rare congenital disorder inherited as an X-linked defect characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3843-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-385C-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"XL- Agammaglobulinemia","valueDescription":"X-Linked Agammaglobulinemia","ValueMeaning":{"publicId":"7515585","version":"1","preferredName":"X-Linked Agammaglobulinemia","longName":"7515585","preferredDefinition":"X-linked agammaglobulinemia.  An immunodeficiency state characterized (usually) by profoundly low concentrations of serum immunoglobulins of all classes, although occasionally significant amounts of one or more isotypes can be found.  The fundamental defect in XLA affects early lineage B cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-Linked Agammaglobulinemia","conceptCode":"C3822","definition":"X-linked agammaglobulinemia.  An immunodeficiency state characterized (usually) by profoundly low concentrations of serum immunoglobulins of all classes, although occasionally significant amounts of one or more isotypes can be found.  The fundamental defect in XLA affects early lineage B cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3869-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3882-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Wiskott-Aldrich Syndrome","valueDescription":"Wiskott-Aldrich syndrome","ValueMeaning":{"publicId":"2579850","version":"1","preferredName":"Wiskott-Aldrich syndrome","longName":"2579850","preferredDefinition":"A rare, X-linked immunodeficiency syndrome characterized by eczema, thrombocytopenia, and recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IgM levels are low and IgA and IgE levels are elevated. Lymphoreticular malignancies are common.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wiskott-Aldrich Syndrome","conceptCode":"C3448","definition":"A rare, X-linked immunodeficiency syndrome characterized by eczema, thrombocytopenia, and recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IgM levels are low and IgA and IgE levels are elevated. Lymphoreticular malignancies are common.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-388C-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"WIP Deficiency","valueDescription":"Wiskott-Aldrich Syndrome 2","ValueMeaning":{"publicId":"7515586","version":"1","preferredName":"Wiskott-Aldrich Syndrome 2","longName":"7515586","preferredDefinition":"An autosomal recessive condition caused by mutation(s) in the WIPF1 gene, encoding WAS/WASL-interacting protein family member 1. It is characterized by recurrent infections, eczema, thrombocytopenia, and T-cell and NK-cell dysfunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wiskott-Aldrich Syndrome 2","conceptCode":"C176820","definition":"An autosomal recessive condition caused by mutation(s) in the WIPF1 gene, encoding WAS/WASL-interacting protein family member 1. It is characterized by recurrent infections, eczema, thrombocytopenia, and T-cell and NK-cell dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3897-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-38B0-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"WHIM","valueDescription":"Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome","ValueMeaning":{"publicId":"7515587","version":"1","preferredName":"Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome","longName":"7515587","preferredDefinition":"An autosomal dominant immunodeficiency syndrome caused by mutation(s) in the CXCR4 gene, encoding C-X-C chemokine receptor type 4. It is characterized by neutropenia, hypogammaglobulinemia, extensive human papillomavirus (HPV) infection, and myelokathexis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome","conceptCode":"C176819","definition":"An autosomal dominant immunodeficiency syndrome caused by mutation(s) in the CXCR4 gene, encoding C-X-C chemokine receptor type 4. It is characterized by neutropenia, hypogammaglobulinemia, extensive human papillomavirus (HPV) infection, and myelokathexis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-38BA-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-38D3-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"STAT5B-LOF","valueDescription":"Inactivating STAT5B Gene Mutation","ValueMeaning":{"publicId":"7515588","version":"1","preferredName":"Inactivating STAT5B Gene Mutation","longName":"7515588","preferredDefinition":"A change in the nucleotide sequence of the STAT5B gene  that either inhibits expression or results in the translation of an inactive signal transducer and activator of transcription 5B protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inactivating STAT5B Gene Mutation","conceptCode":"C176674","definition":"A change in the nucleotide sequence of the STAT5B gene  that either inhibits expression or results in the translation of an inactive signal transducer and activator of transcription 5B protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-38DD-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-38F6-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"STAT-3 GOF","valueDescription":"STAT3 Gain of Function","ValueMeaning":{"publicId":"5207241","version":"1","preferredName":"STAT3 Gain of Function","longName":"5207241","preferredDefinition":"A mutation in the STAT3 gene that results in an increase in cytokine-related function. STAT3 mutations of this type are associated with infantile-onset multisystem autoimmune disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activating STAT3 Gene Mutation","conceptCode":"C126345","definition":"A mutation in the STAT3 gene that results in an increase in cytokine-related function. STAT3 mutations of this type are associated with infantile-onset multisystem autoimmune disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F4A7CBE-8FF5-418E-E050-BB89AD43061D","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-390A-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"STAT1 LOF","valueDescription":"Inactivating STAT1 Gene Mutation","ValueMeaning":{"publicId":"7515589","version":"1","preferredName":"Inactivating STAT1 Gene Mutation","longName":"7515589","preferredDefinition":"A change in the nucleotide sequence of the STAT1 gene that either inhibits expression or results in the translation of an inactive signal transducer and activator of transcription 1-alpha/beta protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inactivating STAT1 Gene Mutation","conceptCode":"C176673","definition":"A change in the nucleotide sequence of the STAT1 gene that either inhibits expression or results in the translation of an inactive signal transducer and activator of transcription 1-alpha/beta protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3915-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-392E-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"STAT-1 GOF","valueDescription":"STAT1 Gain of Function","ValueMeaning":{"publicId":"5207240","version":"1","preferredName":"STAT1 Gain of Function","longName":"5207240","preferredDefinition":"A mutation in the STAT1 gene that results in an increase in cytokine-related functions associated with IFN-alpha/beta, IFN-gamma, IFN-delta, and IL-27. STAT1 mutations of this type are associated with autosomal dominant immunodeficiency 31C.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activating STAT1 Gene Mutation","conceptCode":"C126346","definition":"A mutation in the STAT1 gene that results in an increase in cytokine-related functions associated with IFN-alpha/beta, IFN-gamma, IFN-delta, and IL-27. STAT1 mutations of this type are associated with autosomal dominant immunodeficiency 31C.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F4A7CBE-8FD0-418E-E050-BB89AD43061D","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3942-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Severe neutropenia - congenital X-Linked","valueDescription":"Neutropenia, Severe Congenital, X-Linked","ValueMeaning":{"publicId":"7515590","version":"1","preferredName":"Neutropenia, Severe Congenital, X-Linked","longName":"7515590","preferredDefinition":"An X-linked recessive condition caused by mutation(s) in the WAS gene, encoding Wiskott-Aldrich syndrome protein. It is characterized by severe neutropenia and early onset severe bacterial infections.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neutropenia, Severe Congenital, X-Linked","conceptCode":"C176818","definition":"An X-linked recessive condition caused by mutation(s) in the WAS gene, encoding Wiskott-Aldrich syndrome protein. It is characterized by severe neutropenia and early onset severe bacterial infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-394D-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3966-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Severe Congenital neutropenia (SCN) 1 -  Includes cyclic neutropenia","valueDescription":"Severe Congenital Neutropenia Type 1, Autosomal Dominant","ValueMeaning":{"publicId":"7429582","version":"1","preferredName":"Severe Congenital Neutropenia Type 1, Autosomal Dominant","longName":"7429582","preferredDefinition":"Severe congenital neutropenia inherited in an autosomal dominant pattern and caused by mutation(s) in the ELANE gene, encoding neutrophil elastase","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Congenital Neutropenia Type 1, Autosomal Dominant","conceptCode":"C176827","definition":"Severe congenital neutropenia inherited in an autosomal dominant pattern and caused by mutation(s) in the ELANE gene, encoding neutrophil elastase","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFEDAB8B-9298-632D-E053-4EBD850AD774","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-09-22","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-397A-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"SCN 7 - Autosomal Recessive","valueDescription":"Severe Congenital Neutropenia Type 7, Autosomal Recessive","ValueMeaning":{"publicId":"7515591","version":"1","preferredName":"Severe Congenital Neutropenia Type 7, Autosomal Recessive","longName":"7515591","preferredDefinition":"Severe congenital neutropenia inherited in an autosomal recessive pattern and caused by mutation(s) in the CSF3R gene, encoding granulocyte colony-stimulating factor receptor. It is characterized by the onset of recurrent infections in infancy or early childhood and peripheral neutropenia, despite normal granulocyte maturation, that is unresponsive to treatment with G-CSF.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Congenital Neutropenia Type 7, Autosomal Recessive","conceptCode":"C176614","definition":"Severe congenital neutropenia inherited in an autosomal recessive pattern and caused by mutation(s) in the CSF3R gene, encoding granulocyte colony-stimulating factor receptor. It is characterized by the onset of recurrent infections in infancy or early childhood and peripheral neutropenia, despite normal granulocyte maturation, that is unresponsive to treatment with G-CSF.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3984-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-399D-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"SCN 2 -  Autosomal Dominant","valueDescription":"Severe Congenital Neutropenia Type 2, Autosomal Dominant","ValueMeaning":{"publicId":"7515596","version":"1","preferredName":"Severe Congenital Neutropenia Type 2, Autosomal Dominant","longName":"7515596","preferredDefinition":"Severe congenital neutropenia inherited in an autosomal dominant pattern and caused by mutation(s) in the GFI1 gene, encoding zinc finger protein Gfi-1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Congenital Neutropenia Type 2, Autosomal Dominant","conceptCode":"C176610","definition":"Severe congenital neutropenia inherited in an autosomal dominant pattern and caused by mutation(s) in the GFI1 gene, encoding zinc finger protein Gfi-1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3A28-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3A41-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"RhoH deficiency (RAS Homolog Family member H)","valueDescription":"Epidermodysplasia Verruciformis, Susceptibility to, 4","ValueMeaning":{"publicId":"7515597","version":"1","preferredName":"Epidermodysplasia Verruciformis, Susceptibility to, 4","longName":"7515597","preferredDefinition":"An autosomal recessive condition caused by mutation(s) in the RHOH gene, encoding Rho-related GTP-binding protein RhoH. It presents in childhood and is characterized by defects in T-cell development and signaling leading to increased susceptibility to certain human papilloma viruses (HPV) that cause warty skin lesions that are unresponsive to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidermodysplasia Verruciformis, Susceptibility to, 4","conceptCode":"C176608","definition":"An autosomal recessive condition caused by mutation(s) in the RHOH gene, encoding Rho-related GTP-binding protein RhoH. It presents in childhood and is characterized by defects in T-cell development and signaling leading to increased susceptibility to certain human papilloma viruses (HPV) that cause warty skin lesions that are unresponsive to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3A4B-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3A64-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Reticular dysgenesis (AK2 mutations)","valueDescription":"Reticular Dysgenesis","ValueMeaning":{"publicId":"3326327","version":"1","preferredName":"Reticular Dysgenesis","longName":"3326327","preferredDefinition":"A rare severe combined immunodeficiency disorder characterized by congenital agranulocytosis, lymphoid tissue and thymic tissue hypoplasia, and lymphopenia. Both cellular and humoral immunities are absent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reticular Dysgenesis","conceptCode":"C27070","definition":"A rare severe combined immunodeficiency disorder characterized by congenital agranulocytosis, lymphoid tissue and thymic tissue hypoplasia, and lymphopenia. Both cellular and humoral immunities are absent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3862B52-B5B2-375A-E040-BB89AD436460","latestVersionIndicator":"Yes","beginDate":"2011-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-07","modifiedBy":"ONEDATA","dateModified":"2011-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3A78-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"RAG2 Deficiency","valueDescription":"Severe Combined Immunodeficiency due to RAG2 Deficiency","ValueMeaning":{"publicId":"7515598","version":"1","preferredName":"Severe Combined Immunodeficiency due to RAG2 Deficiency","longName":"7515598","preferredDefinition":"An autosomal recessive condition caused by mutation(s) in the RAG2 gene, encoding V(D)J recombination-activating protein 2. It is characterized by severe combined immunodeficiency that is both T-cell and B-cell negative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency due to RAG2 Deficiency","conceptCode":"C176607","definition":"An autosomal recessive condition caused by mutation(s) in the RAG2 gene, encoding V(D)J recombination-activating protein 2. It is characterized by severe combined immunodeficiency that is both T-cell and B-cell negative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3A83-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3A9C-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"RAG1 Deficiency","valueDescription":"Severe Combined Immunodeficiency due to RAG1 Deficiency","ValueMeaning":{"publicId":"5207239","version":"1","preferredName":"Severe Combined Immunodeficiency due to RAG1 Deficiency","longName":"5207239","preferredDefinition":"An inherited condition caused by mutation(s) in the RAG1 gene, encoding V(D)J recombination-activating protein 1. It is characterized by severe combined immunodeficiency that is both T-cell and B-cell negative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency due to RAG1 Deficiency","conceptCode":"C176606","definition":"An inherited condition caused by mutation(s) in the RAG1 gene, encoding V(D)J recombination-activating protein 1. It is characterized by severe combined immunodeficiency that is both T-cell and B-cell negative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F4A7CBE-8FAB-418E-E050-BB89AD43061D","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3AB0-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"PNP Deficiency","valueDescription":"Purine Nucleoside Phosphorylase Deficiency","ValueMeaning":{"publicId":"7515600","version":"1","preferredName":"Purine Nucleoside Phosphorylase Deficiency","longName":"7515600","preferredDefinition":"A rare autosomal recessive immunodeficiency caused by mutation(s) in the PNP gene, encoding purine nucleoside phosphorylase. It is characterized by recurrent infections resulting from severe T-cell dysfunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Purine Nucleoside Phosphorylase Deficiency","conceptCode":"C176817","definition":"A rare autosomal recessive immunodeficiency caused by mutation(s) in the PNP gene, encoding purine nucleoside phosphorylase. It is characterized by recurrent infections resulting from severe T-cell dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3ADE-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3AF7-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"PIK3CD (GOF)","valueDescription":"Activating PIK3CD Gene Mutation","ValueMeaning":{"publicId":"7515601","version":"1","preferredName":"Activating PIK3CD Gene Mutation","longName":"7515601","preferredDefinition":"A mutation in PIK3CD, the gene encoding the p110delta catalytic subunit of PI3K, that results in induction of PI3K signaling. Mutations of this type are associated with immunodeficiency 14 (PASLI: activated PI3k-delta syndrome, p110-delta-activating mutation causing senescent T-cells, lymphadenopathy, and immunodeficiency).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activating PIK3CD Gene Mutation","conceptCode":"C148028","definition":"A mutation in PIK3CD, the gene encoding the p110delta catalytic subunit of PI3K, that results in induction of PI3K signaling. Mutations of this type are associated with immunodeficiency 14 (PASLI: activated PI3k-delta syndrome, p110-delta-activating mutation causing senescent T-cells, lymphadenopathy, and immunodeficiency).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3B01-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3B1A-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"PIK3 R1 Deficiency (LOF)","valueDescription":"PIK3R1 Deficiency","ValueMeaning":{"publicId":"7515602","version":"1","preferredName":"PIK3R1 Deficiency","longName":"7515602","preferredDefinition":"A deficiency caused by mutation(s) in the PIK3R1 gene, encoding phosphatidylinositol 3-kinase regulatory subunit alpha. It is associated with autosomal recessive agammaglobulinemia 7, immunodeficiency 36 and SHORT (short stature, hyperextensibility of joints or hernia, ocular depression, Rieger anomaly, teething delay) syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PIK3R1 Deficiency","conceptCode":"C176631","definition":"A deficiency caused by mutation(s) in the PIK3R1 gene, encoding phosphatidylinositol 3-kinase regulatory subunit alpha. It is associated with autosomal recessive agammaglobulinemia 7, immunodeficiency 36 and SHORT (short stature, hyperextensibility of joints or hernia, ocular depression, Rieger anomaly, teething delay) syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3B24-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3B3D-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"PGM3 Phosphoglucomutase Deficiency","valueDescription":"PGM3 Deficiency","ValueMeaning":{"publicId":"5207251","version":"1","preferredName":"PGM3 Deficiency","longName":"5207251","preferredDefinition":"A condition of decreased or absent presence or activity of phosphoglucomutase 3. Deficiency of this protein is associated with immunodeficiency 23.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PGM3-Associated Immunodeficiency","conceptCode":"C126339","definition":"A condition of decreased or absent presence or activity of phosphoglucomutase 3. Deficiency of this protein is associated with immunodeficiency 23.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-455C-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3B51-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"3126125","version":"1","preferredName":"Other","longName":"3126125","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D01180C-814A-B8B4-E040-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":"2023.3.7 Alt VM added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C94159-1360-1233-E053-4EBD850AEAAD","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Other Antibody deficiencies","valueDescription":"Other Antibody Deficiency","ValueMeaning":{"publicId":"7515603","version":"1","preferredName":"Other Antibody Deficiency","longName":"7515603","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A protein made by plasma cells (a type of white blood cell) in response to an antigen (a substance that causes the body to make a specific immune response). Each antibody can bind to only one specific antigen. The purpose of this binding is to help destroy the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3B60-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3B79-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"MHC class II deficiency","valueDescription":"MHC Class II Deficiency","ValueMeaning":{"publicId":"7515604","version":"1","preferredName":"MHC Class II Deficiency","longName":"7515604","preferredDefinition":"A genetic disorder caused by molecular defects in the genes encoding for four regulatory factors controlling transcription of MHC class II genes. The phenotype is similar to SCID, and susceptibility to infection by viral, bacterial, fungal and protozoal agents is characteristic of the disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MHC Class II Deficiency","conceptCode":"C176823","definition":"A genetic disorder caused by molecular defects in the genes encoding for four regulatory factors controlling transcription of MHC class II genes. The phenotype is similar to SCID, and susceptibility to infection by viral, bacterial, fungal and protozoal agents is characteristic of the disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3B83-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3B9C-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"LRBA Deficiency","valueDescription":"Immunodeficiency, Common Variable, 8, with Autoimmunity","ValueMeaning":{"publicId":"7515605","version":"1","preferredName":"Immunodeficiency, Common Variable, 8, with Autoimmunity","longName":"7515605","preferredDefinition":"An autosomal recessive common variable immunodeficiency caused by mutation(s) in the LRBA gene, encoding lipopolysaccharide-responsive and beige-like anchor protein. It is characterized by recurrent infections and the development of autoimmune disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency, Common Variable, 8, with Autoimmunity","conceptCode":"C176809","definition":"An autosomal recessive common variable immunodeficiency caused by mutation(s) in the LRBA gene, encoding lipopolysaccharide-responsive and beige-like anchor protein. It is characterized by recurrent infections and the development of autoimmune disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3BA6-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3BBF-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"LCK Deficiency (T Lymphocyte-specific protein TK)","valueDescription":"LCK-Associated Immunodeficiency","ValueMeaning":{"publicId":"7515606","version":"1","preferredName":"LCK-Associated Immunodeficiency","longName":"7515606","preferredDefinition":"An extremely rare autosomal recessive condition caused by mutation(s) in the LCK gene, encoding tyrosine-protein kinase Lck. It is characterized by T-cell dysfunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"LCK-Associated Immunodeficiency","conceptCode":"C176808","definition":"An extremely rare autosomal recessive condition caused by mutation(s) in the LCK gene, encoding tyrosine-protein kinase Lck. It is characterized by T-cell dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3BC9-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3BE2-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"LAT mutations","valueDescription":"LAT Gene Mutation","ValueMeaning":{"publicId":"7515607","version":"1","preferredName":"LAT Gene Mutation","longName":"7515607","preferredDefinition":"A change in the nucleotide sequence of the LAT gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"LAT Gene Mutation","conceptCode":"C176443","definition":"A change in the nucleotide sequence of the LAT gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3BEC-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3C05-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"JAK3 deficiency","valueDescription":"Severe Combined Immunodeficiency, Autosomal Recessive, T-Cell Negative, B-Cell Positive, NK-Cell Negative","ValueMeaning":{"publicId":"7515608","version":"1","preferredName":"Severe Combined Immunodeficiency, Autosomal Recessive, T-Cell Negative, B-Cell Positive, NK-Cell Negative","longName":"7515608","preferredDefinition":"An autosomal recessive severe combined immunodeficiency caused by mutation(s) in the JAK3 gene, encoding tyrosine-protein kinase JAK3. It is characterized by decreased concentrations of T-cells and NK-cells and normal concentrations of B-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency, Autosomal Recessive, T-Cell Negative, B-Cell Positive, NK-Cell Negative","conceptCode":"C176807","definition":"An autosomal recessive severe combined immunodeficiency caused by mutation(s) in the JAK3 gene, encoding tyrosine-protein kinase JAK3. It is characterized by decreased concentrations of T-cells and NK-cells and normal concentrations of B-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3C0F-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3C28-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"JAK1 GOF","valueDescription":"Activating JAK1 Gene Mutation","ValueMeaning":{"publicId":"7515609","version":"1","preferredName":"Activating JAK1 Gene Mutation","longName":"7515609","preferredDefinition":"A change in the nucleotide sequence of the JAK1 gene that that results in constitutive activation of both tyrosine-protein kinase JAK1 and its downstream signaling pathways. These mutations are involved in autoinflammation, immune dysregulation, and eosinophilia (AIIDE).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activating JAK1 Gene Mutation","conceptCode":"C176671","definition":"A change in the nucleotide sequence of the JAK1 gene that that results in constitutive activation of both tyrosine-protein kinase JAK1 and its downstream signaling pathways. These mutations are involved in autoinflammation, immune dysregulation, and eosinophilia (AIIDE).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3C32-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3C4B-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"ITK (IL-2 inducible T cell kinase deficiency)","valueDescription":"ITK Deficiency","ValueMeaning":{"publicId":"5207248","version":"1","preferredName":"ITK Deficiency","longName":"5207248","preferredDefinition":"A condition of decreased or absent presence or activity of IL2-inducible t-cell kinase. Deficiency of this protein is associated with lymphoproliferative syndrome 1, an autosomal recessive primary immunodeficiency characterized by onset in early childhood of Epstein-Barr virus (EBV)-associated immune dysregulation, manifest as lymphoma, lymphomatoid granulomatosis, hemophagocytic lymphohistiocytosis, Hodgkin disease, and/or hypogammaglobulinemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoproliferative Syndrome 1","conceptCode":"C126344","definition":"An autosomal recessive immunodeficiency caused but mutation(s) in the ITK gene, encoding tyrosine-protein kinase ITK/TSK. It is characterized by the early childhood onset of Epstein-Barr virus (EBV)-associated immune dysregulation leading to lymphoma, lymphomatoid granulomatosis, hemophagocytic lymphohistiocytosis, and/or hypogammaglobulinemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-44ED-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3C5F-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IRF8, Dendritic cell immunodeficiency","valueDescription":"Interferon Regulatory Factor 8 Deficiency","ValueMeaning":{"publicId":"7515610","version":"1","preferredName":"Interferon Regulatory Factor 8 Deficiency","longName":"7515610","preferredDefinition":"A genetic condition caused by mutation(s) in the IRF8 gene encoding interferon regulatory factor 8. Autosomal dominant (Immunodeficiency 32A) and autosomal recessive (Immunodeficiency 32B) genetic alterations result in different phenotypes, both of which have impairment of function in dendritic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interferon Regulatory Factor 8 Deficiency","conceptCode":"C176825","definition":"A genetic condition caused by mutation(s) in the IRF8 gene encoding interferon regulatory factor 8. Autosomal dominant (Immunodeficiency 32A) and autosomal recessive (Immunodeficiency 32B) genetic alterations result in different phenotypes, both of which have impairment of function in dendritic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3C6A-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3C83-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IPEX","valueDescription":"Immune Dysregulation, Polyendocrinopathy, and Enteropathy X-Linked Syndrome","ValueMeaning":{"publicId":"7515612","version":"1","preferredName":"Immune Dysregulation, Polyendocrinopathy, and Enteropathy X-Linked Syndrome","longName":"7515612","preferredDefinition":"An X-linked recessive autoimmune condition caused by mutation(s) in the FOXP3 gene, encoding the forkhead box P3 transcription factor. The condition is characterized by infantile onset of severe diarrhea due to enteropathy, type 1 diabetes mellitus, and dermatitis. Associated features may include hypothyroidism, autoimmune hemolytic anemia, thrombocytopenia, lymphadenopathy, hepatitis, and nephritis. The condition is usually fatal before age 2 years if not treated with bone marrow transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Dysregulation, Polyendocrinopathy, and Enteropathy X-Linked Syndrome","conceptCode":"C131009","definition":"An X-linked recessive autoimmune condition caused by mutation(s) in the FOXP3 gene, encoding the forkhead box P3 transcription factor. The condition is characterized by infantile onset of severe diarrhea due to enteropathy, type 1 diabetes mellitus, and dermatitis. Associated features may include hypothyroidism, autoimmune hemolytic anemia, thrombocytopenia, lymphadenopathy, hepatitis, and nephritis. The condition is usually fatal before age 2 years if not treated with bone marrow transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3C90-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3CA9-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"INFGR 2 Deficiency","valueDescription":"Interferon Gamma Receptor 2 Deficiency","ValueMeaning":{"publicId":"7515613","version":"1","preferredName":"Interferon Gamma Receptor 2 Deficiency","longName":"7515613","preferredDefinition":"A genetic condition caused by mutation(s) in the IFNGR2 gene, encoding interferon gamma receptor 2, resulting in impairment of interferon-gamma mediated immunity. Clinically, it is characterized by predisposition to illness caused by moderately virulent mycobacterial species.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interferon Gamma Receptor 2 Deficiency","conceptCode":"C176805","definition":"A genetic condition caused by mutation(s) in the IFNGR2 gene, encoding interferon gamma receptor 2, resulting in impairment of interferon-gamma mediated immunity. Clinically, it is characterized by predisposition to illness caused by moderately virulent mycobacterial species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3CB3-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3CCC-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"INFGR 1 Deficiency","valueDescription":"Interferon Gamma Receptor 1 Deficiency","ValueMeaning":{"publicId":"7515614","version":"1","preferredName":"Interferon Gamma Receptor 1 Deficiency","longName":"7515614","preferredDefinition":"A genetic condition caused by mutation(s) in the IFNGR1 gene, encoding interferon gamma receptor 1, resulting in impairment of interferon-gamma mediated immunity. Clinically, it is characterized by predisposition to illness caused by moderately virulent mycobacterial species.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency 27A","conceptCode":"C176806","definition":"A genetic condition caused by mutation(s) in the IFNGR1 gene, encoding interferon gamma receptor 1, resulting in impairment of interferon-gamma mediated immunity. Clinically, it is characterized by predisposition to illness caused by moderately virulent mycobacterial species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3CD6-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3CEF-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IL7R Deficiency","valueDescription":"Severe Combined Immunodeficiency, Autosomal Recessive, T-Cell Negative, B Cell-Positive, NK Cell-Positive","ValueMeaning":{"publicId":"7515615","version":"1","preferredName":"Severe Combined Immunodeficiency, Autosomal Recessive, T-Cell Negative, B Cell-Positive, NK Cell-Positive","longName":"7515615","preferredDefinition":"An autosomal recessive severe combined immunodeficiency, the phenotype of which is caused by mutation(s) in the IL7R or PTPRC genes, encoding interleukin-7 receptor subunit alpha and receptor-type tyrosine-protein phosphatase C (CD45) respectively.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency, Autosomal Recessive, T-Cell Negative, B Cell-Positive, NK Cell-Positive","conceptCode":"C176804","definition":"An autosomal recessive severe combined immunodeficiency, the phenotype of which is caused by mutation(s) in the IL7R or PTPRC genes, encoding interleukin-7 receptor subunit alpha and receptor-type tyrosine-protein phosphatase C (CD45) respectively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3CF9-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3D12-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IL21 Deficiency","valueDescription":"Immunodeficiency, Common Variable, 11","ValueMeaning":{"publicId":"7515616","version":"1","preferredName":"Immunodeficiency, Common Variable, 11","longName":"7515616","preferredDefinition":"An autosomal recessive subtype of common variable immunodeficiency caused by mutation(s) in the IL21 gene, encoding interleukin-21.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency, Common Variable, 11","conceptCode":"C176801","definition":"An autosomal recessive subtype of common variable immunodeficiency caused by mutation(s) in the IL21 gene, encoding interleukin-21.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3D1C-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3D35-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IL-12 Receptor B Deficiency","valueDescription":"IL12RB1-Associated Immunodeficiency","ValueMeaning":{"publicId":"7515617","version":"1","preferredName":"IL12RB1-Associated Immunodeficiency","longName":"7515617","preferredDefinition":"An autosomal recessive condition caused by mutation(s) in the IL12RB1 gene, encoding interleukin-12 receptor subunit beta-1. It is characterized by a susceptibility to mycobacterial disease. IL12RB1 associated with IL12RB2 results in a high affinity receptor for IL12. IL12RB1 combined with IL23R forms the interleukin-23 receptor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IL12RB1-Associated Immunodeficiency","conceptCode":"C176800","definition":"An autosomal recessive condition caused by mutation(s) in the IL12RB1 gene, encoding interleukin-12 receptor subunit beta-1. It is characterized by a susceptibility to mycobacterial disease. IL12RB1 associated with IL12RB2 results in a high affinity receptor for IL12. IL12RB1 combined with IL23R forms the interleukin-23 receptor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3D3F-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3D58-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IKBKG/NEMO NDAS","valueDescription":"NEMO Deleted Exon 5 Autoinflammatory Syndrome","ValueMeaning":{"publicId":"7515618","version":"1","preferredName":"NEMO Deleted Exon 5 Autoinflammatory Syndrome","longName":"7515618","preferredDefinition":"An autoinflammatory syndrome caused by either gain-of-function splice site variants in the IKBKG gene resulting in a deletion in the C-terminal domain of the NEMO (NF-kappa-B essential modulator) protein or by increased expression of an isoform lacking the domain encoded by exon 5. It is clinically distinct from the immunodeficiency syndromes caused by loss-of-function IKBKG mutations and has features more characteristic of chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NEMO Deleted Exon 5 Autoinflammatory Syndrome","conceptCode":"C176752","definition":"An autoinflammatory syndrome caused by either gain-of-function splice site variants in the IKBKG gene resulting in a deletion in the C-terminal domain of the NEMO (NF-kappa-B essential modulator) protein or by increased expression of an isoform lacking the domain encoded by exon 5. It is clinically distinct from the immunodeficiency syndromes caused by loss-of-function IKBKG mutations and has features more characteristic of chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3D62-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3D7B-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IKBKG/NEMO","valueDescription":"IKBKG Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7508823","version":"1","preferredName":"IKBKG Gene Immunodeficiency Syndrome","longName":"7508823","preferredDefinition":"This gene plays a role in the regulation of signal transduction.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IKBKG Gene","conceptCode":"C75607","definition":"This gene plays a role in the regulation of signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47C2633-F9BB-19EF-E053-4EBD850A09FD","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4CA2F53-3D8F-5B2F-E053-4EBD850A1513","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"AR Agammaglobulinemia","valueDescription":"Autosomal Recessive Agammaglobulinemia ","ValueMeaning":{"publicId":"7515395","version":"1","preferredName":"Autosomal Recessive Agammaglobulinemia ","longName":"7515395","preferredDefinition":"A genetically heterogenous group of primary immunodeficiencies characterized by low or absent circulating antibodies/or and low or absent B-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autosomal Recessive Agammaglobulinemia","conceptCode":"C176822","definition":"A genetically heterogenous group of primary immunodeficiencies characterized by low or absent circulating antibodies/or and low or absent B-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C95360-7A41-23EA-E053-4EBD850A951D","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B71C1C27-B28F-2F56-E053-4EBD850A70DF","beginDate":"2020-11-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-23","modifiedBy":"ONEDATA","dateModified":"2020-12-23","deletedIndicator":"No"},{"value":"PTPRC (CD45 deficiency)","valueDescription":"Severe Combined Immunodeficiency due to CD45 Deficiency","ValueMeaning":{"publicId":"7515599","version":"1","preferredName":"Severe Combined Immunodeficiency due to CD45 Deficiency","longName":"7515599","preferredDefinition":"An autosomal recessive condition caused by mutation(s) in the PTPRC (CD45) gene, encoding receptor-type tyrosine-protein phosphatase C. It is characterized by severe combined immunodeficiency that is T-cell negative, B-cell positive, and NK cell positive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency due to CD45 Deficiency","conceptCode":"C176605","definition":"An autosomal recessive condition caused by mutation(s) in the PTPRC (CD45) gene, encoding receptor-type tyrosine-protein phosphatase C. It is characterized by severe combined immunodeficiency that is T-cell negative, B-cell positive, and NK cell positive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3ABB-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B71C1C27-B2A3-2F56-E053-4EBD850A70DF","beginDate":"2020-11-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-23","modifiedBy":"ONEDATA","dateModified":"2020-12-23","deletedIndicator":"No"},{"value":"SCN 3 (Kostman Syndrome) - Autosomal Recessive","valueDescription":"Autosomal Recessive Severe Congenital Neutropenia","ValueMeaning":{"publicId":"7351353","version":"1","preferredName":"Autosomal Recessive Severe Congenital Neutropenia","longName":"7351353","preferredDefinition":"Severe congenital neutropenia inherited in an autosomal recessive pattern and caused by HCLS1-associated protein X-1 (HAX1) mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Congenital Neutropenia Type 3, Autosomal Recessive","conceptCode":"C166153","definition":"Severe congenital neutropenia inherited in an autosomal recessive pattern and caused by HCLS1-associated protein X-1 (HAX1) mutations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA564E6A-8FA9-5A1D-E053-4EBD850AE182","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-13","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B71C1C27-B2B7-2F56-E053-4EBD850A70DF","beginDate":"2020-11-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-23","modifiedBy":"ONEDATA","dateModified":"2020-12-23","deletedIndicator":"No"},{"value":"SCN 4 (Dursum Syndrome) - Autosomal Recessive","valueDescription":"Severe Congenital Neutropenia Type 4, Autosomal Recessive","ValueMeaning":{"publicId":"7515594","version":"1","preferredName":"Severe Congenital Neutropenia Type 4, Autosomal Recessive","longName":"7515594","preferredDefinition":"Severe congenital neutropenia inherited in an autosomal recessive pattern and caused by mutation(s) in the G6PC3 gene, encoding glucose-6-phosphatase 3. It is characterized by cardiac abnormalities, hepatosplenomegaly, intermittent thrombocytopenia and a prominent superficial venous pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Congenital Neutropenia Type 4, Autosomal Recessive","conceptCode":"C176611","definition":"Severe congenital neutropenia inherited in an autosomal recessive pattern and caused by mutation(s) in the G6PC3 gene, encoding glucose-6-phosphatase 3. It is characterized by cardiac abnormalities, hepatosplenomegaly, intermittent thrombocytopenia and a prominent superficial venous pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-39ED-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B71C1C27-B2CB-2F56-E053-4EBD850A70DF","beginDate":"2020-11-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-23","modifiedBy":"ONEDATA","dateModified":"2020-12-23","deletedIndicator":"No"},{"value":"SCN 5 - Autosomal Recessive","valueDescription":"Severe Congenital Neutropenia Type 5, Autosomal Recessive","ValueMeaning":{"publicId":"7515593","version":"1","preferredName":"Severe Congenital Neutropenia Type 5, Autosomal Recessive","longName":"7515593","preferredDefinition":"Severe congenital neutropenia inherited in an autosomal recessive pattern and caused by mutation(s) in the VPS45 gene, encoding vacuolar protein sorting-associated protein 45. It is characterized by neutrophil dysfunction, a lack of response to G-CSF, life-threatening infections, bone marrow fibrosis, and renal extramedullary hematopoiesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Congenital Neutropenia Type 5, Autosomal Recessive","conceptCode":"C176612","definition":"Severe congenital neutropenia inherited in an autosomal recessive pattern and caused by mutation(s) in the VPS45 gene, encoding vacuolar protein sorting-associated protein 45. It is characterized by neutrophil dysfunction, a lack of response to G-CSF, life-threatening infections, bone marrow fibrosis, and renal extramedullary hematopoiesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-39CA-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B71C1C27-B2DF-2F56-E053-4EBD850A70DF","beginDate":"2020-11-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-23","modifiedBy":"ONEDATA","dateModified":"2020-12-23","deletedIndicator":"No"},{"value":"SCN 6 - Autosomal Recessive","valueDescription":"Severe Congenital Neutropenia Type 6, Autosomal Recessive","ValueMeaning":{"publicId":"7515592","version":"1","preferredName":"Severe Congenital Neutropenia Type 6, Autosomal Recessive","longName":"7515592","preferredDefinition":"Severe congenital neutropenia inherited in an autosomal recessive pattern and caused by mutation(s) in the JAGN1 gene, encoding protein jagunal homolog 1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Congenital Neutropenia Type 6, Autosomal Recessive","conceptCode":"C176602","definition":"Severe congenital neutropenia inherited in an autosomal recessive pattern and caused by mutation(s) in the JAGN1 gene, encoding protein jagunal homolog 1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-39A7-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B71C1C27-B2F3-2F56-E053-4EBD850A70DF","beginDate":"2020-11-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-23","modifiedBy":"ONEDATA","dateModified":"2020-12-23","deletedIndicator":"No"},{"value":"CANDLE","valueDescription":"Proteasome-Associated Autoinflammatory Syndrome 1","ValueMeaning":{"publicId":"7515391","version":"1","preferredName":"Proteasome-Associated Autoinflammatory Syndrome 1","longName":"7515391","preferredDefinition":"An autosomal recessive condition caused by mutation(s) in the PSMB8 gene, encoding proteasome subunit beta type-8. It is characterized by early onset annular erythematous plaques, partial lipodystrophy, and recurrent fever.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proteasome-Associated Autoinflammatory Syndrome 1","conceptCode":"C176619","definition":"An autosomal recessive condition caused by mutation(s) in the PSMB8 gene, encoding proteasome subunit beta type-8. It is characterized by early onset annular erythematous plaques, partial lipodystrophy, and recurrent fever.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C95360-79AC-23EA-E053-4EBD850A951D","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C95360-79C5-23EA-E053-4EBD850A951D","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"ADAM17","valueDescription":"ADAM17 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7508805","version":"1","preferredName":"ADAM17 Gene Immunodeficiency Syndrome","longName":"7508805","preferredDefinition":"This gene plays a role in the cleavage of membrane proteins, resulting in the release of their extracellular domains from cells.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ADAM17 Gene","conceptCode":"C48217","definition":"This gene plays a role in the cleavage of membrane proteins, resulting in the release of their extracellular domains from cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47BAD60-58C5-098D-E053-4EBD850A6E53","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E500-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CAEBV","valueDescription":"Chronic Active Epstein-Barr Virus","ValueMeaning":{"publicId":"5207252","version":"1","preferredName":"Chronic Active Epstein-Barr Virus","longName":"5207252","preferredDefinition":"An on-going Epstein-Barr virus (EBV) infection characterized by repeated infectious mononucleosis-like symptoms, a very high titer of anti-EBV antibodies, and high levels of Epstein-Barr virus nucleic acids. Patients with CAEBV often develop progressive cellular and humoral immunodeficiency with pancytopenia and hypogammaglobulinemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Active EBV Disease","conceptCode":"C126348","definition":"An EBV-positive T-cell/NK-cell lymphoproliferative disorder characterized by repeated infectious mononucleosis-like symptoms, a very high titer of anti-EBV antibodies, and high levels of Epstein-Barr virus nucleic acids. Patients often develop progressive cellular and humoral immunodeficiency with pancytopenia and hypogammaglobulinemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-4581-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C95360-79D9-23EA-E053-4EBD850A951D","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Autosomal dominant Anhidrotic Ectodermal Dysplasia","valueDescription":"Ectodermal Dysplasia and Immunodeficiency 2","ValueMeaning":{"publicId":"7515392","version":"1","preferredName":"Ectodermal Dysplasia and Immunodeficiency 2","longName":"7515392","preferredDefinition":"A rare disorder caused by mutations in the NFKBIA gene resulting in an autosomal dominant inheritance pattern. It is characterized by abnormal development of ectodermal tissues including the skin, hair, teeth, and sweat glands and immune system deficiency. It results in dry and wrinkled skin, sparse scalp and body hair, missing teeth, and reduced ability to sweat. Patients have abnormally low levels of antibodies causing inability to fight infections.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ectodermal Dysplasia and Immunodeficiency 2","conceptCode":"C176826","definition":"A rare disorder caused by mutations in the NFKBIA gene resulting in an autosomal dominant inheritance pattern. It is characterized by abnormal development of ectodermal tissues including the skin, hair, teeth, and sweat glands and immune system deficiency. It results in dry and wrinkled skin, sparse scalp and body hair, missing teeth, and reduced ability to sweat. Patients have abnormally low levels of antibodies causing inability to fight infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C95360-79E4-23EA-E053-4EBD850A951D","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C95360-79FD-23EA-E053-4EBD850A951D","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Artemis SCID","valueDescription":"Severe Combined Immunodeficiency, Athabascan Type","ValueMeaning":{"publicId":"7515394","version":"1","preferredName":"Severe Combined Immunodeficiency, Athabascan Type","longName":"7515394","preferredDefinition":"An autosomal recessive condition caused by mutation(s) in the DCLRE1C gene, encoding protein artemis. It is characterized by severe combined immunodeficiency that is T-cell negative, B-cell negative, NK-cell positive. Sensitivity to ionizing radiation and a high incidence of occurrence amongst the Athabascan Indians are also characteristic of this disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency, Athabascan Type","conceptCode":"C162694","definition":"An autosomal recessive condition caused by mutation(s) in the DCLRE1C gene, encoding protein artemis. It is characterized by severe combined immunodeficiency that is T-cell negative, B-cell negative, NK-cell positive. Sensitivity to ionizing radiation and a high incidence of occurrence amongst the Athabascan Indians are also characteristic of this disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C95360-7A0A-23EA-E053-4EBD850A951D","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C95360-7A23-23EA-E053-4EBD850A951D","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"ARPC1B Deficiency (actin-related protein complex 1B)","valueDescription":"ARPC1B Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7508803","version":"1","preferredName":"ARPC1B Gene Immunodeficiency Syndrome","longName":"7508803","preferredDefinition":"This gene is involved in actin polymerization.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ARPC1B Gene","conceptCode":"C91769","definition":"This gene is involved in actin polymerization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47BAD60-589F-098D-E053-4EBD850A6E53","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C95360-7A37-23EA-E053-4EBD850A951D","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"BACH2","valueDescription":"BACH2 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"4718945","version":"1","preferredName":"BACH2 Gene Immunodeficiency Syndrome","longName":"4718945","preferredDefinition":"This gene is involved in the modulation of transcription.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BACH2 Gene","conceptCode":"C97234","definition":"This gene is involved in the modulation of transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F49E671-4E8B-5BA9-E050-BB89AD436F33","latestVersionIndicator":"Yes","beginDate":"2015-02-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2015-02-17","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E537-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"BCL11B","valueDescription":"BCL11B Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"6140833","version":"1","preferredName":"BCL11B Gene Immunodeficiency Syndrome","longName":"6140833","preferredDefinition":"This gene may play a role in tumor suppression, signaling and T cell development.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCL11B Gene","conceptCode":"C91855","definition":"This gene may play a role in tumor suppression, signaling and T cell development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"678DDF3F-5E2F-7005-E053-F662850AE712","latestVersionIndicator":"Yes","beginDate":"2018-03-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-16","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E542-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CARD 11","valueDescription":"CARD11 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3265347","version":"1","preferredName":"CARD11 Gene Immunodeficiency Syndrome","longName":"3265347","preferredDefinition":"This gene plays a role in apoptotic regulation.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CARD11 Gene","conceptCode":"C60668","definition":"This gene plays a role in apoptotic regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABBB854A-9409-2DD3-E040-BB89AD4312AD","latestVersionIndicator":"Yes","beginDate":"2011-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-30","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E558-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"ADA Deficiency","valueDescription":"Adenosine Deaminase Deficiency","ValueMeaning":{"publicId":"2593377","version":"1","preferredName":"Adenosine Deaminase Deficiency","longName":"2593377","preferredDefinition":"An autosomal recessive deficiency of the purine salvage enzyme adenosine deaminase which results in Severe Combined Immunodeficiency Disease (SCID).  The most common form of SCID, accounting for about 50% of autosomal recessive cases.  The first disease for which gene therapy was applied.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosine Deaminase Deficiency","conceptCode":"C3962","definition":"An autosomal recessive deficiency of the purine salvage enzyme adenosine deaminase which results in Severe Combined Immunodeficiency Disease (SCID).  The most common form of SCID, accounting for about 50% of autosomal recessive cases.  The first disease for which gene therapy was applied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2883B38F-10CD-4337-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C95360-7A6E-23EA-E053-4EBD850A951D","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CORO1A","valueDescription":"CORO1A Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7514987","version":"1","preferredName":"CORO1A Gene Immunodeficiency Syndrome","longName":"7514987","preferredDefinition":"This gene is involved in membrane dynamics in motile cells.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CORO1A Gene","conceptCode":"C176417","definition":"This gene is involved in membrane dynamics in motile cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C83A9D-D210-23EE-E053-4EBD850A41A4","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E5C6-619D-E053-4EBD850A30E4","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"ERBIN","valueDescription":"ERBIN Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7508807","version":"1","preferredName":"ERBIN Gene Immunodeficiency Syndrome","longName":"7508807","preferredDefinition":"This gene is involved in signal transduction and protein localization and function.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ERBIN Gene","conceptCode":"C24374","definition":"This gene is involved in signal transduction and protein localization and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47BE127-0B98-1197-E053-4EBD850A4AB9","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E629-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"FOXN1","valueDescription":"FOXN1 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7514985","version":"1","preferredName":"FOXN1 Gene Immunodeficiency Syndrome","longName":"7514985","preferredDefinition":"This gene plays a role in development of the thymic epithelium, differentiation of T lineage progenitors and keratinization of the skin.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FOXN1 Gene","conceptCode":"C176420","definition":"This gene plays a role in development of the thymic epithelium, differentiation of T lineage progenitors and keratinization of the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C83A9D-D1CA-23EE-E053-4EBD850A41A4","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E634-619D-E053-4EBD850A30E4","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"GATA2","valueDescription":"GATA2 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3773972","version":"1","preferredName":"GATA2 Gene Immunodeficiency Syndrome","longName":"3773972","preferredDefinition":"This gene is involved in both DNA binding and transcriptional regulation.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GATA2 Gene","conceptCode":"C97552","definition":"This gene is involved in both DNA binding and transcriptional regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE090BF0-CB47-F2E9-E040-BB89AD437E15","latestVersionIndicator":"Yes","beginDate":"2013-05-31","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-05-31","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E655-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"HOIL1","valueDescription":"RBCK1 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7514980","version":"1","preferredName":"RBCK1 Gene Immunodeficiency Syndrome","longName":"7514980","preferredDefinition":"This gene is involved in the polyubiquitination of protein substrates.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RBCK1 Gene","conceptCode":"C176427","definition":"This gene is involved in the polyubiquitination of protein substrates.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C83A9D-D11B-23EE-E053-4EBD850A41A4","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E681-619D-E053-4EBD850A30E4","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"HOIP","valueDescription":"RNF31 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7514979","version":"1","preferredName":"RNF31 Gene Immunodeficiency Syndrome","longName":"7514979","preferredDefinition":"This gene plays a role in polyubiquitination and inflammation.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RNF31 Gene","conceptCode":"C176431","definition":"This gene plays a role in polyubiquitination and inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C83A9D-D0F8-23EE-E053-4EBD850A41A4","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E68C-619D-E053-4EBD850A30E4","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"ICOS","valueDescription":"ICOS Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3541556","version":"1","preferredName":"ICOS Gene Immunodeficiency Syndrome","longName":"3541556","preferredDefinition":"This gene is involved in the immune response.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ICOS Gene","conceptCode":"C94801","definition":"This gene is involved in the immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C661F4F8-E1C0-BB1A-E040-BB89AD436C64","latestVersionIndicator":"Yes","beginDate":"2012-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-03","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E697-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IKBKB","valueDescription":"IKBKB Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"6141216","version":"1","preferredName":"IKBKB Gene Immunodeficiency Syndrome","longName":"6141216","preferredDefinition":"This gene is involved in protein phosphorylation.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IKBKB Gene","conceptCode":"C96383","definition":"This gene is involved in protein phosphorylation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67920436-43BC-59BF-E053-F662850A03A9","latestVersionIndicator":"Yes","beginDate":"2018-03-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-16","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E6C3-619D-E053-4EBD850A30E4","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IKZF1","valueDescription":"IKZF1 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3425256","version":"1","preferredName":"IKZF1 Gene Immunodeficiency Syndrome","longName":"3425256","preferredDefinition":"This gene is involved in B-cell and T-cell maturation.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IKZF1 Gene","conceptCode":"C68730","definition":"This gene is involved in B-cell and T-cell maturation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC61C31B-421F-4F48-E040-BB89AD434E83","latestVersionIndicator":"Yes","beginDate":"2012-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-29","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E6D9-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IL10","valueDescription":"IL10 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7485632","version":"1","preferredName":"IL10 Gene Immunodeficiency Syndrome","longName":"7485632","preferredDefinition":"This gene plays an anti-inflammatory role in immune processes and is involved in a variety of diseases.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IL10 Gene","conceptCode":"C28600","definition":"This gene plays an anti-inflammatory role in immune processes and is involved in a variety of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D4EF97-BA24-1D89-E053-4EBD850A174A","latestVersionIndicator":"Yes","beginDate":"2020-10-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-29","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E6E4-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IL10RA","valueDescription":"IL10RA Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3855352","version":"1","preferredName":"IL10RA Gene Immunodeficiency Syndrome","longName":"3855352","preferredDefinition":"This gene plays a role in immunosuppression.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IL10RA Gene","conceptCode":"C107582","definition":"This gene plays a role in immunosuppression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3EDB9F5-0D62-CBBB-E040-BB89AD437DF9","latestVersionIndicator":"Yes","beginDate":"2013-08-14","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-08-14","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E6EF-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IL10RB","valueDescription":"IL10RB Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7508821","version":"1","preferredName":"IL10RB Gene Immunodeficiency Syndrome","longName":"7508821","preferredDefinition":"This gene plays a role in cytokine regulation and signal transduction.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IL10RB Gene","conceptCode":"C24492","definition":"This gene plays a role in cytokine regulation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47C2633-F976-19EF-E053-4EBD850A09FD","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E6FA-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IL21R","valueDescription":"IL21R Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"4170880","version":"1","preferredName":"IL21R Gene Immunodeficiency Syndrome","longName":"4170880","preferredDefinition":"This gene is involved in cytokine recognition.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IL21R Gene","conceptCode":"C68736","definition":"This gene is involved in cytokine recognition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3291B7E-D442-AB08-E040-BB89AD437FF9","latestVersionIndicator":"Yes","beginDate":"2014-02-24","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-02-24","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E71B-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IL2RA","valueDescription":"IL2RA Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7508819","version":"1","preferredName":"IL2RA Gene Immunodeficiency Syndrome","longName":"7508819","preferredDefinition":"This gene plays a role in clathrin-independent endocytosis and immune functions.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IL2RA Gene","conceptCode":"C21563","definition":"This gene plays a role in clathrin-independent endocytosis and immune functions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47C2633-F930-19EF-E053-4EBD850A09FD","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E726-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"IRF2BP2","valueDescription":"IRF2BP2 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7508813","version":"1","preferredName":"IRF2BP2 Gene Immunodeficiency Syndrome","longName":"7508813","preferredDefinition":"This gene plays a role in transcriptional repression.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IRF2BP2 Gene","conceptCode":"C107664","definition":"This gene plays a role in transcriptional repression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47C2633-F8B4-19EF-E053-4EBD850A09FD","latestVersionIndicator":"Yes","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E773-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"ITCH","valueDescription":"ITCH Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7515006","version":"1","preferredName":"ITCH Gene Immunodeficiency Syndrome","longName":"7515006","preferredDefinition":"This gene is involved in protein ubiquitination that promotes protein degradation and regulates inflammatory signaling pathways.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ITCH Gene","conceptCode":"C176435","definition":"This gene is involved in protein ubiquitination that promotes protein degradation and regulates inflammatory signaling pathways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C86B77-E403-619D-E053-4EBD850A30E4","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E789-619D-E053-4EBD850A30E4","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"MALT1","valueDescription":"MALT1 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3234663","version":"1","preferredName":"MALT1 Gene Immunodeficiency Syndrome","longName":"3234663","preferredDefinition":"This gene plays a role in signal transduction and in the pathology of mucosa-associated lymphoid tissue lymphomas.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MALT1 Gene","conceptCode":"C60671","definition":"This gene plays a role in signal transduction and in the pathology of mucosa-associated lymphoid tissue lymphomas.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3158B0D-13C0-9FBA-E040-BB89AD431012","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E80D-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"MSN","valueDescription":"MSN Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"6142168","version":"1","preferredName":"MSN Gene Immunodeficiency Syndrome","longName":"6142168","preferredDefinition":"This gene plays a role in both cell adhesion and cytoskeleton modeling.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MSN Gene","conceptCode":"C97621","definition":"This gene plays a role in both cell adhesion and cytoskeleton modeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67CCB734-F124-4B40-E053-F662850A71CC","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-19","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C86B77-E818-619D-E053-4EBD850A30E4","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"ICF","valueDescription":"DNA (Cytosine-5-)-Methyltransferase 3B","ValueMeaning":{"publicId":"3638074","version":"1","preferredName":"DNA (Cytosine-5-)-Methyltransferase 3B","longName":"3638074","preferredDefinition":"DNA (cytosine-5)-methyltransferase 3B (853 aa, ~96 kDa) is encoded by the human DNMT3B gene. This protein is involved in DNA methylation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA (Cytosine-5)-Methyltransferase 3B","conceptCode":"C26112","definition":"DNA (cytosine-5)-methyltransferase 3B (853 aa, ~96 kDa) is encoded by the human DNMT3B gene. This protein is involved in DNA methylation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0216124-A10B-F193-E040-BB89AD436E45","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-66B8-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Hyper IgE Recurrent infection syndrome (Job's)","valueDescription":"STAT3 Deficiency","ValueMeaning":{"publicId":"5207242","version":"1","preferredName":"STAT3 Deficiency","longName":"5207242","preferredDefinition":"A condition of decreased or absent presence or activity of signal transducer and activator of transcription 3 protein. Deficiency of this protein is associated with hyper-IgE syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"STAT3 Deficiency","conceptCode":"C126342","definition":"A condition of decreased or absent presence or activity of signal transducer and activator of transcription 3 protein. Deficiency of this protein is associated with hyper-IgE syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F4A7CBE-901A-418E-E050-BB89AD43061D","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-66CD-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Hemophagocytic Lymphohistiocytosis (HLH)","valueDescription":"Hemophagocytic Lymphohistiocytosis","ValueMeaning":{"publicId":"3211128","version":"1","preferredName":"Hemophagocytic Lymphohistiocytosis","longName":"3211128","preferredDefinition":"A rare but potentially life-threatening disorder characterized by the proliferation of histiocytes and macrophages and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary, due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophagocytic Lymphohistiocytosis","conceptCode":"C34792","definition":"A rare, but potentially life-threatening disorder, characterized by the proliferation of histiocytes and macrophages, and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-D1E6-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-66E2-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"DOCK2 Deficiency","valueDescription":"DOCK2-Associated Immunodeficiency","ValueMeaning":{"publicId":"7515408","version":"1","preferredName":"DOCK2-Associated Immunodeficiency","longName":"7515408","preferredDefinition":"An autosomal recessive combined immunodeficiency caused by mutation(s) in the DOCK2 gene, encoding dedicator of cytokinesis protein 2. It is characterized by combined immunodeficiency, primarily affecting T-cells, with more variable defects in B-cell and NK-cell function, resulting in viral and bacterial infections that may lead to death in severe cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DOCK2-Associated Immunodeficiency","conceptCode":"C176799","definition":"An autosomal recessive combined immunodeficiency caused by mutation(s) in the DOCK2 gene, encoding dedicator of cytokinesis protein 2. It is characterized by combined immunodeficiency, primarily affecting T-cells, with more variable defects in B-cell and NK-cell function, resulting in viral and bacterial infections that may lead to death in severe cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C8BD61-66ED-77C4-E053-4EBD850A3A57","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-6706-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"DOCK 8 Deficiency","valueDescription":"DOCK8 Deficiency","ValueMeaning":{"publicId":"5207250","version":"1","preferredName":"DOCK8 Deficiency","longName":"5207250","preferredDefinition":"A condition of decreased or absent presence or activity of dedicator of cytokinesis protein 8. Deficiency of this protein is associated with autosomal recessive hyper-IgE recurrent infection syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DOCK8 Deficiency","conceptCode":"C126343","definition":"A condition of decreased or absent presence or activity of dedicator of cytokinesis protein 8. Deficiency of this protein is associated with autosomal recessive hyper-IgE recurrent infection syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-4537-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-671A-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"DNA PKcs deficiency","valueDescription":"Immunodeficiency 26 with or without Neurologic Abnormalities","ValueMeaning":{"publicId":"7515409","version":"1","preferredName":"Immunodeficiency 26 with or without Neurologic Abnormalities","longName":"7515409","preferredDefinition":"An autosomal recessive severe combined immunodeficiency caused by mutation(s) in the PRKDC gene, encoding DNA-dependent protein kinase catalytic subunit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency 26 with or without Neurologic Abnormalities","conceptCode":"C176795","definition":"An autosomal recessive severe combined immunodeficiency caused by mutation(s) in the PRKDC gene, encoding DNA-dependent protein kinase catalytic subunit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C8BD61-6725-77C4-E053-4EBD850A3A57","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-673E-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"DNA ligase IV deficiency","valueDescription":"LIG4 Syndrome","ValueMeaning":{"publicId":"7515411","version":"1","preferredName":"LIG4 Syndrome","longName":"7515411","preferredDefinition":"A very rare genetic disorder caused by mutation in the LIG4 gene.  It is characterized by unusual facial features, microcephaly, growth and developmental delay, severe immunodeficiency, and skin abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"LIG4 Syndrome","conceptCode":"C122657","definition":"A very rare genetic disorder caused by mutation in the LIG4 gene.  It is characterized by unusual facial features, microcephaly, growth and developmental delay, severe immunodeficiency, and skin abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C8BD61-674B-77C4-E053-4EBD850A3A57","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-6764-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"DADA2","valueDescription":"Adenosine Deaminase 2 Deficiency","ValueMeaning":{"publicId":"5207238","version":"1","preferredName":"Adenosine Deaminase 2 Deficiency","longName":"5207238","preferredDefinition":"A disorder characterized by abnormal inflammation of various tissues, particularly the blood vessels, with intermittent. fevers, areas of net-like, mottled skin discoloration (livedo racemosa), hepatosplenomegaly, and recurrent strokes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosine Deaminase 2 Deficiency","conceptCode":"C126347","definition":"A disorder characterized by abnormal inflammation of various tissues, particularly the blood vessels, with intermittent. fevers, areas of net-like, mottled skin discoloration (livedo racemosa), hepatosplenomegaly, and recurrent strokes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F4A7CBE-8F86-418E-E050-BB89AD43061D","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-6778-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CXCL4 Deficiency (alter neutrophil recruitment)","valueDescription":"PF4 Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7515412","version":"1","preferredName":"PF4 Gene Immunodeficiency Syndrome","longName":"7515412","preferredDefinition":"This gene plays a role in platelet aggregation and promotes blood coagulation.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PF4 Gene","conceptCode":"C26600","definition":"This gene plays a role in platelet aggregation and promotes blood coagulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C8BD61-6783-77C4-E053-4EBD850A3A57","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-679C-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CVID","valueDescription":"Common Variable Immunodeficiency","ValueMeaning":{"publicId":"2579841","version":"1","preferredName":"Common Variable Immunodeficiency","longName":"2579841","preferredDefinition":"A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Variable Immunodeficiency","conceptCode":"C26725","definition":"A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04EE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.20 Updated definition to use current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-67B0-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CTLA4 Deficiency","valueDescription":"CTLA4 Haploinsufficiency; CHAI; ALPS5","ValueMeaning":{"publicId":"5207234","version":"1","preferredName":"CTLA4 Haploinsufficiency; CHAI; ALPS5","longName":"5207234","preferredDefinition":"A somatic mutation in the CTLA4 gene resulting in only a single functional gene. Haploinsufficiency for CTLA4 is associated with autoimmune lymphoproliferative syndrome, type V.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CTLA4 Deficiency","conceptCode":"C126341","definition":"A genetic condition caused by mutation(s) in the CTLA4 gene, encoding cytotoxic T-lymphocyte protein 4. Cytotoxic T-lymphocyte protein 4 is an inhibitory receptor acting as a negative regulator of T-cells, and two functional copies of the gene are required for normal immune function. Clinically, it may be characterized by gastrointestinal symptoms, lymphadenopathy, hepatomegaly, and splenomegaly, and autoimmune disorders. Mutations(s) in CTLA4 are also associated with autoimmune lymphoproliferative syndrome, type V.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-4411-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-67C5-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CID with multiple intestinal atresia CID-MI","valueDescription":"Gastrointestinal Defects and Immunodeficiency Syndrome","ValueMeaning":{"publicId":"7515413","version":"1","preferredName":"Gastrointestinal Defects and Immunodeficiency Syndrome","longName":"7515413","preferredDefinition":"An autosomal recessive condition caused by mutation(s) in the TTC7A gene encoding tetratricopeptide repeat protein 7A. It is characterized by multiple intestinal atresia, multi-organ impairment and associated with T- and B-cell dysfunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Defects and Immunodeficiency Syndrome","conceptCode":"C176792","definition":"An autosomal recessive condition caused by mutation(s) in the TTC7A gene encoding tetratricopeptide repeat protein 7A. It is characterized by multiple intestinal atresia, multi-organ impairment and associated with T- and B-cell dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C8BD61-67D0-77C4-E053-4EBD850A3A57","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-67E9-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"Cernunnos / XLF deficiency","valueDescription":"Severe Combined Immunodeficiency due to NHEJ1 Deficiency","ValueMeaning":{"publicId":"7515414","version":"1","preferredName":"Severe Combined Immunodeficiency due to NHEJ1 Deficiency","longName":"7515414","preferredDefinition":"An autosomal recessive condition caused by mutation(s) in the NHEJ1 gene, encoding non-homologous end-joining factor 1. It is characterized by severe combined immunodeficiency that is T-cell negative, B-cell negative, NK-cell positive. Microcephaly, growth retardation, and sensitivity to ionizing radiation are also characteristic of this disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency due to NHEJ1 Deficiency","conceptCode":"C162695","definition":"An autosomal recessive condition caused by mutation(s) in the NHEJ1 gene, encoding non-homologous end-joining factor 1. It is characterized by severe combined immunodeficiency that is T-cell negative, B-cell negative, NK-cell positive. Microcephaly, growth retardation, and sensitivity to ionizing radiation are also characteristic of this disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C8BD61-67F3-77C4-E053-4EBD850A3A57","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-680C-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CD40 Ligand deficiency (XL hyper IgM)","valueDescription":"CD40 Ligand Deficiency","ValueMeaning":{"publicId":"3377507","version":"1","preferredName":"CD40 Ligand Deficiency","longName":"3377507","preferredDefinition":"Patients with the X-linked hyper IgM syndrome have a deficiency of a protein, CD40 ligand that is found on the surface of T-lymphocytes. As a consequence of the deficiency of this protein, their T-lymphocytes are unable to instruct B-lymphocytes to switch their production of gamma globulins from IgM to IgG and IgA. As a result, patients have decreased levels of IgG and IgA and normal or elevated levels of IgM. In addition, since CD40 ligand is important to other functions of T-lymphocytes, they also have a defect in some of the protective functions of their T-lymphocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD40 Ligand Deficiency","conceptCode":"C61244","definition":"Patients with the X-linked hyper IgM syndrome have a deficiency of a protein, CD40 ligand that is found on the surface of T-lymphocytes. As a consequence of the deficiency of this protein, their T-lymphocytes are unable to instruct B-lymphocytes to switch their production of gamma globulins from IgM to IgG and IgA. As a result, patients have decreased levels of IgG and IgA and normal or elevated levels of IgM. In addition, since CD40 ligand is important to other functions of T-lymphocytes, they also have a defect in some of the protective functions of their T-lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8E0919B-1304-9720-E040-BB89AD434D99","latestVersionIndicator":"Yes","beginDate":"2012-02-13","endDate":null,"createdBy":"NYCHM","dateCreated":"2012-02-13","modifiedBy":"ONEDATA","dateModified":"2012-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-6820-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"CD40 deficiency","valueDescription":"Immunodeficiency with Hyper-IgM, Type 3","ValueMeaning":{"publicId":"7515415","version":"1","preferredName":"Immunodeficiency with Hyper-IgM, Type 3","longName":"7515415","preferredDefinition":"An autosomal recessive subtype of immunodeficiency with hyper-IgM caused by mutation(s) in the CD40 gene, encoding tumor necrosis factor receptor superfamily member 5.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency with Hyper-IgM, Type 3","conceptCode":"C176416","definition":"An autosomal recessive subtype of immunodeficiency with hyper-IgM caused by mutation(s) in the CD40 gene, encoding tumor necrosis factor receptor superfamily member 5.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C8BD61-682B-77C4-E053-4EBD850A3A57","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B4C8BD61-6844-77C4-E053-4EBD850A3A57","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","deletedIndicator":"No"},{"value":"PTEN","valueDescription":"PTEN Deficiency","ValueMeaning":{"publicId":"6423766","version":"1","preferredName":"PTEN Deficiency","longName":"6423766","preferredDefinition":"A condition of decreased or absent presence or activity of phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, which is associated with multiple hamartoma syndrome (Cowden syndrome) and increased risk for development of several types of malignant cancers, including head and neck, breast, lung and prostate cancer and glioblastoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PTEN Deficiency","conceptCode":"C153467","definition":"A condition of decreased or absent presence or activity of phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, which is associated with multiple hamartoma syndrome (Cowden syndrome) and increased risk for development of several types of malignant cancers, including head and neck, breast, lung and prostate cancer and glioblastoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520033E-D128-2151-E053-F662850A12D0","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-09-05","modifiedBy":"COLBERTM","dateModified":"2018-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B68286CE-E4BA-6BDC-E053-4EBD850AA51C","beginDate":"2020-11-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7533514","version":"1","preferredName":"Immunodeficiency Syndrome Name","preferredDefinition":"A deficiency of immune response or a disorder characterized by deficient immune response.:The words or language units by which a thing is known.","longName":"C3131:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B68530BD-B138-06D3-E053-4EBD850AC5D1","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C86B77-E4D2-619D-E053-4EBD850A30E4","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":"2021-1-19 ak Added missing PV concepts. Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020.  AK 2020-11-23","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease","type":"Preferred Question Text","description":"Disease","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6853381-5D9A-06D5-E053-4EBD850A0E44","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeDescription":"Approved for import and released. mc 12.23.2020; 2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}